Scholars@Duke

Table S3 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Publication ,  Other
Paller, CJ; Zahurak, ML; Mandl, A; Metri, NA; Lalji, A; Heath, E; Kelly, WK; Hoimes, C; Barata, P; Taksey, J; Garrison, DA; Patra, K ...
September 25, 2024
Published version (DOI) Publisher Link

<p>Table S3 shows Adverse Events Included in the Co-Primary Endpoint: All Occurrences</p>

Duke Scholars

Christopher Hoimes
Author Christopher Hoimes Medicine, Medical Oncology

DOI

10.1158/2767-9764.27101875

Publication Date

September 25, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paller, C. J., Zahurak, M. L., Mandl, A., Metri, N. A., Lalji, A., Heath, E., … Levine, M. (2024). Table S3 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. https://doi.org/10.1158/2767-9764.27101875
Paller, Channing J., Marianna L. Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth Heath, William K. Kelly, et al. “Table S3 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial,” September 25, 2024. https://doi.org/10.1158/2767-9764.27101875.
Paller CJ, Zahurak ML, Mandl A, Metri NA, Lalji A, Heath E, Kelly WK, Hoimes C, Barata P, Taksey J, Garrison DA, Patra K, Milne GL, Anders NM, Nauroth JM, Durham JN, Marshall CH, Markowski MC, Eisenberger MA, Antonarakis ES, Carducci MA, Denmeade SR, Levine M. Table S3 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. 2024.

DOI

10.1158/2767-9764.27101875

Publication Date

September 25, 2024